www.nature.com/articles/s41...
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
www.healthbeat.org/newyork/2025...
www.healthbeat.org/newyork/2025...
- from @columbiauniversity.bsky.social
@icahn.bsky.social
@yalemedicine.bsky.social
@stanfordimmunology.bsky.social
@benaroyaresearch.bsky.social
@lji.org
MIT, Seattle Children's
#AAI2025
#ImmuneSky #IDsky
- from @columbiauniversity.bsky.social
@icahn.bsky.social
@yalemedicine.bsky.social
@stanfordimmunology.bsky.social
@benaroyaresearch.bsky.social
@lji.org
MIT, Seattle Children's
#AAI2025
#ImmuneSky #IDsky
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Proud of my group and collaborators for this work published today in Nature Medicine. We find Cytomegalovirus, which has a profound impact on T cell immunity, is associated with distinct clinical outcomes in patients receiving checkpoint immunotherapy for melanoma.
Proud of my group and collaborators for this work published today in Nature Medicine. We find Cytomegalovirus, which has a profound impact on T cell immunity, is associated with distinct clinical outcomes in patients receiving checkpoint immunotherapy for melanoma.
scim.ag/430weCB
scim.ag/430weCB
Delightful to have been part of the all new UK guidelines on the diagnosis of and management of eosinophilia!
www.journalofinfection.com/article/S016...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
doi.org/10.1084/jem....
doi.org/10.1084/jem....
academic.oup.com/cid/advance-...
academic.oup.com/cid/advance-...
p.s. only possible since I've been directly involved with several papers that meet these exact criteria, so mea culpa
blogs.jwatch.org/hiv-id-obser...
p.s. only possible since I've been directly involved with several papers that meet these exact criteria, so mea culpa
blogs.jwatch.org/hiv-id-obser...
bit.ly/SI_adp3720
bit.ly/SI_adp3720
www.bennett.ox.ac.uk/blog/2024/10...
www.bennett.ox.ac.uk/blog/2024/10...
Impressive.
Key take homes for me.
1) Time to result still long - addressable but a barrier currently.
2) 10% contamination.
3) Despite using cutting edge tests a "causative" organism found in only 15%.
Impressive.
Key take homes for me.
1) Time to result still long - addressable but a barrier currently.
2) 10% contamination.
3) Despite using cutting edge tests a "causative" organism found in only 15%.
A breakthrough cancer immunotherapy is now taking aim at autoimmune disease | Science | AAAS www.science.org/content/arti...
A breakthrough cancer immunotherapy is now taking aim at autoimmune disease | Science | AAAS www.science.org/content/arti...